November 20, 2013

Nuclea received the accreditation based on the results of a recent site visit inspection.

Pittsfield, MA—Nuclea Biotechnologies today announced they had received accreditation from the College of American Pathologists. Nuclea received the inspection as a result of their continuing expansion of the company’s portfolio to provide more diagnostic assays to the public.

The CAP inspection involves examination of a laboratory’s records and quality control of procedures for the two years prior to accreditation. Laboratory staff’s qualifications, equipment, facilities, safety program and record, and overall management are also evaluated in the course of accreditation.

The facility director, Deborah A. August, MD said “it is an honor to receive the accreditation. The CAP Laboratory Accreditation Program is a stringent, effective certification that will only help us to provide even better care to laboratory patients in the future.”

“We are excited CAP re-accredited the Nuclea CLIA Laboratory,” said Patrick J. Muraca, President and CEO of Nuclea. “As Nuclea continues to grow and innovate, it’s great to have the recognition of such a prominent and trustworthy accreditation group. This is further confirmation that our hard work and talented employees are the gold standard of excellence in the Massachusetts biotech community.”

Nuclea Biotechnologies, Inc. -- is headquartered in Pittsfield, Massachusetts with additional operations in Worcester and Cambridge, Massachusetts. Nuclea has developed and is commercializing unique diagnostic tests for colon, breast, leukemia, lung and prostate cancer. Nuclea also performs research leading to novel molecular oncology companion diagnostics for the pharmaceutical and biotechnology industries.

The College of American Pathologists--is a medical society that serves more than 18,000 physician members and the global laboratory community. It is the world’s largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care. More information about the CAP can be found


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.